Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.76 USD | +3.71% | +44.48% | +49.64% |
May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 181M | Sales 2025 * | 249M | Capitalization | 593M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | 21M | EV / Sales 2024 * | 3.27 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.38 x |
P/E ratio 2024 * |
-30.8
x | P/E ratio 2025 * |
29.8
x | Employees | 315 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.92% |
Latest transcript on Harrow, Inc.
1 day | +3.71% | ||
1 week | +44.48% | ||
Current month | +64.47% | ||
1 month | +41.79% | ||
3 months | +57.08% | ||
6 months | +87.05% | ||
Current year | +49.64% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Andrew Boll
DFI | Director of Finance/CFO | 41 | 11-11-30 |
Jamie Webb
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Director/Board Member | 65 | Jan. 25 | |
Adrienne Graves
BRD | Director/Board Member | 69 | Jan. 25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 16.76 | +3.71% | 546,507 |
24-05-16 | 16.16 | +1.48% | 512,999 |
24-05-15 | 15.92 | -1.94% | 1,013,789 |
24-05-14 | 16.24 | +34.55% | 2,820,478 |
24-05-13 | 12.07 | +4.05% | 832,176 |
Delayed Quote OTC Markets, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.64% | 593M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- HROW Stock